Victor Wembanyama returns to lead 2025-26 San Antonio Spurs, aside fellow Rookie of the Year Stephon Castle and No. 2 pick Dylan Harper.

An observational study was conducted across three Spanish hospitals to compare two glucocorticoid regimens in treating 151 patients newly diagnosed with giant cell arteritis (mean age, 74.6 years; 71% ...

Scuderia Ferrari Formula One driver Charles Leclerc's name has appeared in a brainwave data breach following an investigation. It is alleged that China might have stolen brainwave data through a focus ...

Defendant Dakota Van Patten looks out at the gallery during his trial at the Linn County Courthouse in Cedar Rapids on Thursday. Van Patten is charged with first-degree murder, kidnapping and ...

Federal prosecutors are nearing the end of their case in the trial of Ryan Routh, accused of attempting to assassinate Donald Trump. FBI agents testified that cell phone and license plate data tracked ...

PMV Pharmaceuticals has reported a 43% response rate in a midphase ovarian cancer trial, putting the biotech on a track it believes will lead to a filing for FDA approval in the first quarter of 2027.

Third Person Shooter Two more heroes have been leaked for Marvel Rivals, but unless NetEase plans to turn Deadpool into a healer, I don't want either in Season 4 Third Person Shooter Marvel Rivals ...

Fully Equipped's Johnny Wunder and Jake Morrow are joined by Softspikes Charles Woodward to discuss how combo sets can improve your swing's efficiency. DC March Against Trump Draws Huge Turnout ...

The U.S. Food and Drug Administration (FDA) on Thursday granted Breakthrough Therapy designation to Eli Lilly and Co.’s (NYSE:LLY) olomorasib, in combination with Merck & Co. Inc.’s (NYSE:MRK) anti-PD ...

All five patients in a trial with recurrent glioblastoma given a combination of ImmunityBio's (NASDAQ:IBRX) natural killer (NK) cell therapy Anktiva and Novocure's (NASDAQ:NVCR) Optune Gio Tumor ...

A man with type 1 diabetes has become the first patient to produce his own insulin after receiving genetically engineered cell transplants, without needing drugs to prevent rejection. The case, ...